Moreover, the NLRP3 inflammasome blockade suppresses head and neck squamous cell carcinomas (HNSCC) growth by downregulating IL-1βexpression and reducing MDSCs, PD-1 and tumor-associated Macrophages (TAMs) in head and neck squamous cell carcinoma100. Here, NLRP3 is linked to neoplasm.